632.895(8)(e)1.
1. The woman does not have an assigned or regular physician or nurse practitioner when the examination is performed.
632.895(8)(e)2.
2. The woman designates a physician to receive the results of the examination.
632.895(8)(e)3.
3. Any examination by low-dose mammography previously obtained by the woman was at the direction of a licensed physician or a nurse practitioner.
632.895(8)(f)
(f) This subsection does not apply to any of the following:
632.895(8)(f)1.
1. A disability insurance policy that only provides coverage of certain specified diseases.
632.895(8)(f)3.
3. A medicare replacement policy, a medicare supplement policy or a long-term care insurance policy.
632.895(9)
(9) Drugs for treatment of HIV infection. 632.895(9)(a)(a) In this subsection, “HIV infection" means the pathological state produced by a human body in response to the presence of HIV, as defined in s.
631.90 (1).
632.895(9)(b)
(b) Except as provided in par.
(d), every disability insurance policy that is issued or renewed on or after April 28, 1990, and that provides coverage of prescription medication shall provide coverage for each drug that satisfies all of the following:
632.895(9)(b)1.
1. Is prescribed by the insured's physician for the treatment of HIV infection or an illness or medical condition arising from or related to HIV infection.
632.895(9)(b)2.
2. Is approved by the federal food and drug administration for the treatment of HIV infection or an illness or medical condition arising from or related to HIV infection, including each investigational new drug that is approved under
21 CFR 312.34 to
312.36 for the treatment of HIV infection or an illness or medical condition arising from or related to HIV infection and that is in, or has completed, a phase 3 clinical investigation performed in accordance with
21 CFR 312.20 to
312.33.
632.895(9)(b)3.
3. If the drug is an investigational new drug described in subd.
2., is prescribed and administered in accordance with the treatment protocol approved for the investigational new drug under
21 CFR 312.34 to
312.36.
632.895(9)(c)
(c) Coverage of a drug under par.
(b) may be subject to any copayments and deductibles that the disability insurance policy applies generally to other prescription medication covered by the disability insurance policy.
632.895(9)(d)
(d) This subsection does not apply to any of the following:
632.895(9)(d)1.
1. A disability insurance policy that covers only certain specified diseases.
632.895(9)(d)3.
3. A medicare replacement policy or a medicare supplement policy.
632.895(10)(a)
(a) Except as provided in par.
(b), every disability insurance policy and every health care benefits plan provided on a self-insured basis by a county board under s.
59.52 (11), by a city or village under s.
66.0137 (4), by a local governmental unit or technical college district under s.
66.0137 (4m), by a town under s.
60.23 (25), or by a school district under s.
120.13 (2) shall provide coverage for blood lead tests for children under 6 years of age, which shall be conducted in accordance with any recommended lead screening methods and intervals contained in any rules promulgated by the department of health services under s.
254.158.
632.895(10)(b)
(b) This subsection does not apply to any of the following:
632.895(10)(b)1.
1. A disability insurance policy that covers only certain specified diseases.
632.895(11)
(11) Treatment for the correction of temporomandibular disorders. 632.895(11)(a)(a) Except as provided in par.
(e), every disability insurance policy, and every self-insured health plan of the state or a county, city, village, town or school district, that provides coverage of any diagnostic or surgical procedure involving a bone, joint, muscle or tissue shall provide coverage for diagnostic procedures and medically necessary surgical or nonsurgical treatment for the correction of temporomandibular disorders if all of the following apply:
632.895(11)(a)1.
1. The condition is caused by congenital, developmental or acquired deformity, disease or injury.